U.S. Ranbaxy Court Action Stirs Concern In Indian Drug Industry
This article was originally published in PharmAsia News
Executive Summary
India's generic drug industry is concerned U.S. government accusations of adulterated drugs marketed by Ranbaxy Laboratories could have a widespread effect. Some industry representatives expect anti-generics lobbyists to take advantage of the lawsuit. The industry experts also believe the entire Indian drug-making industry, which has enjoyed a good safety record, could become viewed with caution. There also is the possibility of medical professionals around the world becoming suspicious of Indian products. (Click here for more